Chemicals - Specialty
Compare Stocks
4 / 10Stock Comparison
EMN vs LIN vs APD vs ALB
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
EMN vs LIN vs APD vs ALB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $8.43B | $228.85B | $65.68B | $23.37B |
| Revenue (TTM) | $8.64B | $34.66B | $12.46B | $5.49B |
| Net Income (TTM) | $399M | $7.13B | $2.11B | $-233M |
| Gross Margin | 19.8% | 46.0% | 32.0% | 18.5% |
| Operating Margin | 9.4% | 28.8% | 18.4% | 5.6% |
| Forward P/E | 12.5x | 27.7x | 22.5x | 22.4x |
| Total Debt | $5.08B | $26.99B | $18.41B | $3.30B |
| Cash & Equiv. | $566M | $5.06B | $1.86B | $1.62B |
EMN vs LIN vs APD vs ALB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
| Linde plc (LIN) | 100 | 244.1 | +144.1% |
| Air Products and Ch… (APD) | 100 | 122.1 | +22.1% |
| Albemarle Corporati… (ALB) | 100 | 259.2 | +159.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EMN vs LIN vs APD vs ALB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EMN is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (12.5x vs 22.4x)
- 4.5% yield, 12-year raise streak, vs APD's 2.4%
LIN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 375.2% 10Y total return vs ALB's 217.0%
- Lower volatility, beta 0.24, Low D/E 67.9%, current ratio 0.88x
- PEG 1.09 vs EMN's 3.89
APD is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 29 yrs, beta 0.45, yield 2.4%
- Beta 0.45, yield 2.4%, current ratio 1.38x
ALB is the clearest fit if your priority is momentum.
- +256.7% vs EMN's +2.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs EMN's -6.7% | |
| Value | Lower P/E (12.5x vs 22.4x) | |
| Quality / Margins | 20.6% margin vs ALB's -4.2% | |
| Stability / Safety | Beta 0.24 vs ALB's 1.60 | |
| Dividends | 4.5% yield, 12-year raise streak, vs APD's 2.4% | |
| Momentum (1Y) | +256.7% vs EMN's +2.3% | |
| Efficiency (ROA) | 8.3% ROA vs ALB's -1.4%, ROIC 11.3% vs 0.6% |
EMN vs LIN vs APD vs ALB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EMN vs LIN vs APD vs ALB — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LIN leads in 3 of 6 categories
EMN leads 1 • APD leads 0 • ALB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 6.3x ALB's $5.5B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to ALB's -4.2%. On growth, ALB holds the edge at +32.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $8.6B | $34.7B | $12.5B | $5.5B |
| EBITDAEarnings before interest/tax | $1.2B | $12.1B | $3.9B | $802M |
| Net IncomeAfter-tax profit | $399M | $7.1B | $2.1B | -$233M |
| Free Cash FlowCash after capex | $498M | $5.1B | $1.1B | $577M |
| Gross MarginGross profit ÷ Revenue | +19.8% | +46.0% | +32.0% | +18.5% |
| Operating MarginEBIT ÷ Revenue | +9.4% | +28.8% | +18.4% | +5.6% |
| Net MarginNet income ÷ Revenue | +4.6% | +20.6% | +16.9% | -4.2% |
| FCF MarginFCF ÷ Revenue | +5.8% | +14.7% | +8.9% | +10.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.9% | +8.2% | +8.8% | +32.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -40.8% | +13.4% | +141.1% | — |
Valuation Metrics
EMN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, EMN trades at a 47% valuation discount to LIN's 33.8x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.33x vs EMN's 5.59x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $8.4B | $228.8B | $65.7B | $23.4B |
| Enterprise ValueMkt cap + debt − cash | $12.9B | $250.8B | $82.2B | $25.1B |
| Trailing P/EPrice ÷ TTM EPS | 17.97x | 33.85x | -166.67x | -34.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.50x | 27.67x | 22.46x | 22.36x |
| PEG RatioP/E ÷ EPS growth rate | 5.59x | 1.33x | — | — |
| EV / EBITDAEnterprise value multiple | 8.96x | 19.75x | 119.66x | 33.21x |
| Price / SalesMarket cap ÷ Revenue | 0.96x | 6.73x | 5.46x | 4.55x |
| Price / BookPrice ÷ Book value/share | 1.41x | 5.82x | 3.79x | 2.39x |
| Price / FCFMarket cap ÷ FCF | 19.87x | 44.97x | — | 33.76x |
Profitability & Efficiency
LIN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-2 for ALB. ALB carries lower financial leverage with a 0.34x debt-to-equity ratio, signaling a more conservative balance sheet compared to APD's 1.06x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs APD's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.7% | +17.8% | +11.9% | -2.3% |
| ROA (TTM)Return on assets | +2.6% | +8.3% | +5.1% | -1.4% |
| ROICReturn on invested capital | +6.7% | +11.3% | -2.0% | +0.6% |
| ROCEReturn on capital employed | +7.5% | +13.0% | -2.4% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 2 | 6 |
| Debt / EquityFinancial leverage | 0.84x | 0.68x | 1.06x | 0.34x |
| Net DebtTotal debt minus cash | $4.5B | $21.9B | $16.6B | $1.7B |
| Cash & Equiv.Liquid assets | $566M | $5.1B | $1.9B | $1.6B |
| Total DebtShort + long-term debt | $5.1B | $27.0B | $18.4B | $3.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.22x | 34.52x | 12.00x | 1.59x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,394 today (with dividends reinvested), compared to $7,163 for EMN. Over the past 12 months, ALB leads with a +256.7% total return vs EMN's +2.3%. The 3-year compound annual growth rate (CAGR) favors LIN at 11.8% vs EMN's 1.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.8% | +15.5% | +19.2% | +38.1% |
| 1-Year ReturnPast 12 months | +2.3% | +11.2% | +14.2% | +256.7% |
| 3-Year ReturnCumulative with dividends | +3.4% | +39.7% | +7.0% | +9.3% |
| 5-Year ReturnCumulative with dividends | -28.4% | +73.9% | +13.2% | +26.8% |
| 10-Year ReturnCumulative with dividends | +35.4% | +375.2% | +166.4% | +217.0% |
| CAGR (3Y)Annualised 3-year return | +1.1% | +11.8% | +2.3% | +3.0% |
Risk & Volatility
Evenly matched — LIN and APD each lead in 1 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than ALB's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APD currently trades 96.0% from its 52-week high vs EMN's 87.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.36x | 0.24x | 0.45x | 1.60x |
| 52-Week HighHighest price in past year | $84.18 | $521.28 | $307.29 | $221.00 |
| 52-Week LowLowest price in past year | $56.11 | $387.78 | $229.11 | $53.70 |
| % of 52W HighCurrent price vs 52-week peak | +87.5% | +94.7% | +96.0% | +89.8% |
| RSI (14)Momentum oscillator 0–100 | 56.9 | 51.7 | 55.0 | 53.0 |
| Avg Volume (50D)Average daily shares traded | 1.5M | 2.3M | 1.2M | 2.0M |
Analyst Outlook
Evenly matched — EMN and APD each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EMN as "Buy", LIN as "Buy", APD as "Buy", ALB as "Hold". Consensus price targets imply 9.3% upside for LIN (target: $540) vs -3.8% for ALB (target: $191). For income investors, EMN offers the higher dividend yield at 4.47% vs ALB's 0.82%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $77.29 | $539.71 | $312.78 | $190.80 |
| # AnalystsCovering analysts | 35 | 28 | 42 | 45 |
| Dividend YieldAnnual dividend ÷ price | +4.5% | +1.2% | +2.4% | +0.8% |
| Dividend StreakConsecutive years of raises | 12 | 6 | 29 | 15 |
| Dividend / ShareAnnual DPS | $3.30 | $6.00 | $7.11 | $1.62 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | +2.0% | 0.0% | 0.0% |
LIN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMN leads in 1 (Valuation Metrics). 2 tied.
EMN vs LIN vs APD vs ALB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EMN or LIN or APD or ALB a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Eastman Chemical Company (EMN) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EMN or LIN or APD or ALB?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
0x versus Linde plc at 33. 8x. On forward P/E, Eastman Chemical Company is actually cheaper at 12. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 09x versus Eastman Chemical Company's 3. 89x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — EMN or LIN or APD or ALB?
Over the past 5 years, Linde plc (LIN) delivered a total return of +73.
9%, compared to -28. 4% for Eastman Chemical Company (EMN). Over 10 years, the gap is even starker: LIN returned +375. 2% versus EMN's +35. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EMN or LIN or APD or ALB?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Albemarle Corporation's 1. 60β — meaning ALB is approximately 565% more volatile than LIN relative to the S&P 500. On balance sheet safety, Albemarle Corporation (ALB) carries a lower debt/equity ratio of 34% versus 106% for Air Products and Chemicals, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EMN or LIN or APD or ALB?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Albemarle Corporation grew EPS 48. 7% year-over-year, compared to -110. 3% for Air Products and Chemicals, Inc.. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EMN or LIN or APD or ALB?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -9. 9% for Albemarle Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -7. 3% for APD. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EMN or LIN or APD or ALB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 09x versus Eastman Chemical Company's 3. 89x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Eastman Chemical Company (EMN) trades at 12. 5x forward P/E versus 27. 7x for Linde plc — 15. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 9. 3% to $539. 71.
08Which pays a better dividend — EMN or LIN or APD or ALB?
All stocks in this comparison pay dividends.
Eastman Chemical Company (EMN) offers the highest yield at 4. 5%, versus 0. 8% for Albemarle Corporation (ALB).
09Is EMN or LIN or APD or ALB better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +375. 2% 10Y return). Albemarle Corporation (ALB) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, ALB: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EMN and LIN and APD and ALB?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EMN is a small-cap deep-value stock; LIN is a large-cap quality compounder stock; APD is a mid-cap quality compounder stock; ALB is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.